Evaluation of the Impact of Renal Function on the Pharmacokinetics of SIKLOS ® (DARH)

Clinical trial NCT02522104 · COMPLETED

Trial details

NCT number: NCT02522104
Sponsor: Theravia
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Sickle Cell Disease Renal Function Disorder

Start date: 2015-09-03
Primary completion: 2016-11-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.